Releases › HCPCS Level II October 2024
HCPCS Level II October 2024
Effective 2024-10-01 to 2024-12-31. 8,474 codes in the release.
58added
10revised
6removed
Codes added 58
| Code | Description |
|---|---|
| A2027 | Matriderm, per square centimeter |
| A2028 | Micromatrix flex, per mg |
| A2029 | Mirotract wound matrix sheet, per cubic centimeter |
| A4543 | Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month |
| A4544 | Electrode for external lower extremity nerve stimulator for restless legs syndrome |
| A4545 | Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel pads, electrodes, etc.), needed for one month |
| A7021 | Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter) |
| A9610 | Xenon xe-129 hyperpolarized gas, diagnostic, per study dose |
| C8000 | Support device, extravascular, for arteriovenous fistula (implantable) |
| C9169 | Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram |
| C9170 | Injection, tarlatamab-dlle, 1 mg |
| C9171 | Injection, pegulicianine, 1 mg |
| C9172 | Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose |
| E0469 | Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device |
| E0683 | Non-pneumatic, non-sequential, peristaltic wave compression pump |
| E0715 | Intravaginal device intended to strengthen pelvic floor muscles during kegel exercises |
| E0716 | Supplies and accessories for intravaginal device intended to strengthen pelvic floor muscles during kegel exercises |
| E0721 | Transcutaneous electrical nerve stimulator for nerves in the auricular region |
| E0737 | Transcutaneous tibial nerve stimulator, controlled by phone application |
| E0743 | External lower extremity nerve stimulator for restless legs syndrome, each |
| E0767 | Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories |
| E2513 | Accessory for speech generating device, electromyographic sensor |
| E3200 | Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only |
| J0138 | Injection, acetaminophen 10 mg and ibuprofen 3 mg |
| J0175 | Injection, donanemab-azbt, 2 mg |
| J1171 | Injection, hydromorphone, 0.1 mg |
| J1749 | Injection, iloprost, 0.1 mcg |
| J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg |
| J2003 | Injection, lidocaine hydrochloride, 1 mg |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg |
| J2252 | Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg |
| J2253 | Injection, midazolam (seizalam), 1 mg |
| J2601 | Injection, vasopressin (baxter), 1 unit |
| J8522 | Capecitabine, oral, 50 mg |
| J8541 | Dexamethasone (hemady), oral, 0.25 mg |
| J9329 | Injection, tislelizumab-jsgr, 1mg |
| L1006 | Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla to trochanter, includes all accessory pads, straps and interface, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
| L1653 | Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, off the shelf |
| L1821 | Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, off the shelf |
| L8720 | External lower extremity sensory prosthesis, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg |
| L8721 | Receptor sole for use with l8720, replacement, each |
| P9027 | Red blood cells, leukocytes reduced, oxygen/ carbon dioxide reduced, each unit |
| Q0519 | Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days |
| Q0520 | Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days |
| Q4334 | Amnioplast 1, per square centimeter |
| Q4335 | Amnioplast 2, per square centimeter |
| Q4336 | Artacent c, per square centimeter |
| Q4337 | Artacent trident, per square centimeter |
| Q4338 | Artacent velos, per square centimeter |
| Q4339 | Artacent vericlen, per square centimeter |
| Q4340 | Simpligraft, per square centimeter |
| Q4341 | Simplimax, per square centimeter |
| Q4342 | Theramend, per square centimeter |
| Q4343 | Dermacyte ac matrix amniotic membrane allograft, per square centimeter |
| Q4344 | Tri-membrane wrap, per square centimeter |
| Q4345 | Matrix hd allograft dermis, per square centimeter |
| Q5135 | Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg |
| Q5136 | Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg |
Descriptions revised 10
| Code | Was, and is now |
|---|---|
| A2024 | |
| A4271 | |
| E0739 | |
| J2251 | |
| J9172 | |
| L1652 | |
| L1820 | |
| Q0516 | |
| Q0517 | |
| Q0518 |
Terminated 6
| Code | Description |
|---|---|
| C9150 | Xenon xe-129 hyperpolarized gas, diagnostic, per study dose |
| J1170 | Injection, hydromorphone, up to 4 mg |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg |
| J8520 | Capecitabine, oral, 150 mg |
| J8521 | Capecitabine, oral, 500 mg |
| J9258 | Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg |